Screenshot 2025-08-18 at 7.37.36 PM858748 111 KB Onesource speciality OneSource Specialty Pharma is an India-based CDMO spanning biologics, complex injectables, soft-gel capsules, and drug-device combos
[] The most challenging differential diagnosis is between DM and cutaneous MPNST since both neoplasms show S100 positivity (mainly the epithelioid variant of MPNST) and can lack IHC markers of melanocytic differentiation
Build trust in each interaction by actively listening, demonstrating genuine compassion, maintaining eye contact and personalizing messaging
The FDA-approved titration schedule for Zepbound begins at 2.5 mg weekly, with increases no sooner than every 4 weeks through sequential doses of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and up to a maximum maintenance dose of 15 mg weekly, depending on individual response and tolerability